SeqLL has acquired the rights to true Single Molecule Sequencing (tSMS®).
We are re-engineering and have re-introduced the technology to the research, biopharma and healthcare communities on a fee for service basis.
We offer RNA sequencing, specialized DNA sequencing and bioinformatic services that leverage the unique strengths of the tSMS technology platform to solve unmet needs for our customers.